Departments of Obstetrics and Gynaecology (Dr. Tranoulis).
Department of Obstetrics and Gynaecology (Dr. Georgiou), Chelsea and Westminster NHS Trust, Imperial College, London, United Kingdom.
J Minim Invasive Gynecol. 2019 Jul-Aug;26(5):826-837. doi: 10.1016/j.jmig.2019.02.004. Epub 2019 Feb 15.
To ascertain the efficacy and safety of laparoscopic uterine artery occlusion (LUAO) during laparoscopic myomectomy (LM) on intra- and postoperative morbidity and to assess its impact on leiomyoma recurrence rates.
MEDLINE, Scopus, Web of Science, and Cochrane Database were searched for relevant references from inception until December 2018, in line with PRISMA guidelines.
Two authors screened for study eligibility and extracted data. Randomized controlled trials (RCTs) and observational studies (OSs) comparing short- and long-term morbidity of LM with or without LUAO were included. The modified Jadad score and the methodologic index for nonrandomized studies were used to evaluate the quality of RCTs and OSs, respectively.
TABULATION, INTEGRATION, AND RESULTS: Twelve studies encompassing 750 LM and 873 LUAO-LM cases were included in the meta-analysis. The studies were of moderate quality. LUAO-LM appears to significantly decrease intraoperative blood loss, postoperative hemoglobin drop, and blood transfusion rate. A trend toward shorter hospital length of stay was demonstrated, whereas no significant difference in operation duration was observed. The combined procedure seemingly contributes to lower recurrence rate. No LUAO-related complications were reported. Moderate to high heterogeneity was observed for few outcomes.
This is the first meta-analysis to date to provide a convincing overview of efficacy and safety of LUAO-LM. Although a medium risk of bias warrants some caution with interpretation of the results, LUAO-LM seemingly improves intra- and postoperative outcomes in women with symptomatic leiomyomas.
确定腹腔镜子宫动脉阻断术(LUAO)在腹腔镜子宫肌瘤剔除术(LM)中对术中及术后发病率的疗效和安全性,并评估其对子宫肌瘤复发率的影响。
根据 PRISMA 指南,在 MEDLINE、Scopus、Web of Science 和 Cochrane 数据库中检索了从开始到 2018 年 12 月的相关参考文献。
两名作者筛选了研究的合格性并提取了数据。纳入了比较 LM 与 LUAO-LM 的短期和长期发病率的随机对照试验(RCT)和观察性研究(OS)。分别使用改良 Jadad 评分和非随机研究方法指标评估 RCT 和 OS 的质量。
列表、整合和结果:12 项研究共纳入了 750 例 LM 和 873 例 LUAO-LM 病例,进行了荟萃分析。这些研究的质量为中等。LUAO-LM 似乎显著减少了术中出血量、术后血红蛋白下降和输血率。显示出住院时间缩短的趋势,但手术时间无显著差异。联合手术似乎有助于降低复发率。未报告与 LUAO 相关的并发症。少数结局存在中度至高度异质性。
这是迄今为止首次提供 LUAO-LM 的疗效和安全性的令人信服的综述的荟萃分析。尽管存在中度偏倚风险,因此对结果的解释需要谨慎,但 LUAO-LM 似乎改善了有症状子宫肌瘤妇女的围手术期结局。